NCT03019159

Brief Summary

The objective of the study is to determine whether tele-consulting for the follow up of patients with renal failure under peritoneal dialysis would not increase the risk of experiencing a severe adverse event

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2014

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 10, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 12, 2017

Completed
Last Updated

January 12, 2017

Status Verified

June 1, 2014

Enrollment Period

2 years

First QC Date

January 10, 2017

Last Update Submit

January 10, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Severe adverse events

    Death, Peritonitis, acute pulmonary edema, symptomatic hyperkalemia or with EKG signs, severe and resistant hypertension, with uremia \> 40 mmol/L

    Within 2 years after enrollment

Secondary Outcomes (7)

  • Number of hospitalisations

    Within 2 years after enrollment

  • Number of consultations

    Within 2 years after enrollment

  • Number of sanitary transportation

    Within 2 years after enrollment

  • Mean length of hospital stay

    Within 2 years after enrollment

  • Global costs

    6 months after the first patient enrollment

  • +2 more secondary outcomes

Study Arms (2)

Tele-consulting

One visit out of two takes place with teleconsulting and the other is a face-to-face consultation

Device: Teleconsulting

No tele-consulting

Interventions

Also known as: Telemedicine
Tele-consulting

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with renal failure under peritoneal dialysis

You may qualify if:

  • Patient under peritoneal dialysis for more than three month
  • Patient thought to be able to perform peritoneal dialysis alone or with the help of health care professionnals
  • Patients or health care professionnals thought to be able to use telemedicine

You may not qualify if:

  • No DSL Network
  • No GSM Network
  • Patients who can not express their opposition to the participation to this study because of limited mental abilities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CTIRC - Hôpitaux Saint Maurice

Saint-Maurice, 94410, France

Location

Related Publications (2)

  • Gallar P, Vigil A, Rodriguez I, Ortega O, Gutierrez M, Hurtado J, Oliet A, Ortiz M, Mon C, Herrero JC, Lentisco C. Two-year experience with telemedicine in the follow-up of patients in home peritoneal dialysis. J Telemed Telecare. 2007;13(6):288-92. doi: 10.1258/135763307781644906.

    PMID: 17785025BACKGROUND
  • Kidholm K, Ekeland AG, Jensen LK, Rasmussen J, Pedersen CD, Bowes A, Flottorp SA, Bech M. A model for assessment of telemedicine applications: mast. Int J Technol Assess Health Care. 2012 Jan;28(1):44-51. doi: 10.1017/S0266462311000638.

    PMID: 22617736BACKGROUND

Related Links

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Stéphane Roueff, MD

    Pôle CTIRC. Hôpitaux Saint Maurice

    PRINCIPAL INVESTIGATOR
  • Isabelle Durand-Zaleski, MD, PhD

    DRCD URC Eco. Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2017

First Posted

January 12, 2017

Study Start

September 1, 2014

Primary Completion

September 1, 2016

Study Completion

September 1, 2016

Last Updated

January 12, 2017

Record last verified: 2014-06

Locations